Last Updated: August 9, 2026

Patent: 5,153,657


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,153,657
Title: Cleaning blade wear life extension by inorganic fillers reinforcement
Abstract:A cleaning blade which is made from an elastomeric matrix having inorganic particulates homogenously dispersed therein. The cleaning blade is used in an electrophotographic printing machine to remove residual particles from a photoconductive imaging member surface.
Inventor(s): Yu; Robert C. U. (Webster, NY), Lindblad; Nero R. (Ontario, NY)
Assignee: Xerox Corporation (Stamford, CT)
Application Number:07/693,104
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Critical Patent Landscape Analysis for US Patent 5,153,657 (Cleaning Blade With Thermoset Elastomer and Inorganic Wear-Resistant Filler)

US 5,153,657 claims a cleaning blade for frictional particle removal in which a thermoset elastomeric matrix contains an inorganic particulate filler for wear resistance. The claim set narrows on (i) filler hardness (4 to 7 Mohs), (ii) particle aspect ratio (<10:1), (iii) matrix polymer family (polyurethanes, caprolactones, polyesters, polyethers), and (iv) specific filler size and morphology ranges (including a mean particle size of ~2.5 micrometers in claim 5 and cylindrical fillers with 1 to 3 micrometers diameter and 3 to 10 micrometers length in claim 7). The claim list also expands filler scope to a very large set of minerals, glasses, fibers, and ceramic particulates and adds surface treatment via coupling agents (silanes/titanates/zirconates/aluminates) in claims 8 and 9.

What is claimed, in technical terms

What does claim 1 require?

Claim 1 establishes the independent structure:

  • Use/function: a cleaning blade in frictional engagement with a surface to remove particles
  • Blade body material: thermoset elastomeric matrix material
  • Wear filler: an inorganic particulate filler dispersed in the thermoset elastomer
  • Hardness window: filler hardness 4 to 7 Mohs

This creates a material-structure-function link: wear resistance is obtained by embedding mid-hardness inorganic particulates in a crosslinked elastomer.

What additional constraints do the dependent claims add?

  • Claim 2: filler aspect ratio <10:1
  • Claim 3: matrix chosen from polyurethane, caprolactones, polyesters, polyethers
  • Claim 4: filler is substantially homogeneously dispersed
  • Claim 5: filler mean particle size about 2.5 μm
  • Claim 7: another independent formulation adds morphology:
    • inorganic filler selected from a large set
    • filler has cylindrical shape:
    • 1 to 3 μm diameter
    • 3 to 10 μm length
  • Claims 8-9: filler surface treated with coupling agents:
    • Claim 8: coupling agent applied to inorganic particles
    • Claim 9: coupling agent includes silanes, titanates, zirconates, aluminates

Claim-by-claim “attack map” for validity and non-infringement

The most business-relevant questions are: (1) what elements are likely already disclosed in earlier cleaning-blade elastomer systems, (2) which elements are most likely to be deemed novel or non-obvious, and (3) what design-arounds are available without giving up core performance.

Is the hardness range (4 to 7 Mohs) a novelty hook?

Claim 1’s 4 to 7 Mohs hardness range is a potential novelty hook because it is not simply “abrasive filler” but a bounded hardness window.

However, the hard reality of prior art in elastomer compounding is that fillers like silica (Mohs ~7), alumina (~9), and many glasses/minerals are widely used broadly for wear and abrasion. A prior art disclosure often does not state an identical Mohs range, but it may disclose:

  • inorganic wear fillers in elastomers generally; and/or
  • silica/ceramics with hardness values bracketing or overlapping 4 to 7 Mohs;
  • elastomer formulations for scraping/cleaning with inorganic fillers.

For enforceability, the novelty argument would hinge on whether prior art framed the hardness in that specific window and linked it to blade wear performance in frictional cleaning use. If earlier documents disclose mid-hardness fillers within a comparable elastomer matrix for frictional cleaning, then the range may be treated as an obvious selection.

Does the “thermoset elastomeric matrix” narrow enough?

“Thermoset elastomeric matrix” can be a meaningful constraint if prior art is largely thermoplastic. But the claim language is broad: it includes elastomeric matrices that are thermoset and selected from polyurethanes/caprolactones/polyesters/polyethers (claim 3). Prior art in scraper blades often uses polyurethane systems; some are thermoset or crosslinked depending on curing routes. If a prior art blade uses crosslinked polyurethane with inorganic filler for wear, claim 3 may not be a strong differentiator.

Do the particle aspect ratio and size limitations create enforceable separation?

  • Claim 2 (<10:1 aspect ratio) limits the filler shape to avoid very high-aspect fillers.
  • Claim 5 (~2.5 μm mean particle size) is a tight number.
  • Claim 7 introduces an additional independent scope with cylindrical filler geometry (1 to 3 μm diameter, 3 to 10 μm length).

These can be enforceable if prior art uses significantly different particle sizes or morphologies (e.g., larger particulates, flakes with higher aspect ratios, or different filler geometry such as fibers/talc plates), or if prior art does not teach cylindrical fillers.

Yet the filler list itself is huge. If prior art discloses that fillers such as glass fibers, basalt fibers, mineral whiskers, and various ceramics are embedded to improve abrasion resistance in elastomers, then claim 7’s geometry could be considered a routine optimization absent a performance nexus stated in the specification.

Are the coupling agents a clear differentiator?

Claims 8 and 9 add surface treatment with silanes/titanates/zirconates/aluminates. Coupling agents are standard in polymer composite technology to improve filler-matrix adhesion. For novelty, the differentiator would have to be whether the combination of:

  • thermoset elastomer blade,
  • frictional cleaning,
  • specific inorganic filler set,
  • and coupling agent selection was not previously taught together.

If earlier composite wear-blade patents already disclose coupling-agent-treated inorganic fillers, the coupling agent claims may be vulnerable to obviousness.

Practical interpretation of the filler list: scope breadth vs. novelty

What does the filler enumeration accomplish?

Claims 6 and 7 include a very long list of minerals, glasses, ceramic particles, and fibers. That enumeration does two things:

  • Broadly captures alternative materials that share hardness and wear function.
  • Creates a risk for novelty arguments: a broad list suggests the invention may be driven by the concept of using inorganic particulate fillers generally, bounded by hardness and particle features, rather than by a single specific mineral.

Is claim scope tied to functional criteria or just material identity?

In claim 1, filler identity is not limited; only hardness and being inorganic particulate dispersed in thermoset elastomer matters. The enumeration in claim 6 is limiting, but only for claim 6 dependent coverage, not for claim 1.

For claim coverage breadth, the strongest enforceable core is:

  • frictional cleaning blade,
  • thermoset elastomeric matrix,
  • inorganic particulate filler,
  • hardness 4 to 7 Mohs.

The strongest differentiator is the specific hardness window combined with the blade function and thermoset elastomer matrix.

Non-infringement and design-around options (what to change)

The fastest way to assess infringement risk is to target claim elements likely to be easiest to modify.

What to change to avoid claim 1’s hardest constraints?

  • Move filler hardness outside 4 to 7 Mohs, for example:
    • lower hardness fillers (below ~4 Mohs), or
    • higher hardness abrasives (above ~7 Mohs).
  • Replace thermoset elastomer matrix with a thermoplastic elastomer system.
  • Use non-particulate fillers or fillers not meeting “inorganic particulate filler” (e.g., polymeric microspheres) to break the claim requirement.

What to change to avoid claims 2, 5, and 7?

  • Change filler morphology so aspect ratio is not <10:1.
  • Change mean particle size to not be around 2.5 μm.
  • For the cylindrical filler-dependent scope (claim 7), avoid:
    • cylindrical particles with 1 to 3 μm diameter and 3 to 10 μm length.

What to change to avoid claims 8 and 9?

  • Omit coupling agents (or use different surface chemistries not including silanes/titanates/zirconates/aluminates, depending on how the specification defines “includes” coverage).

Landscape dynamics: where similar inventions typically sit

In cleaning blades, wiper blades, and scraper components, the dominant commercial approaches are:

  • polyurethane-based blade bodies (often crosslinked),
  • fillers for wear resistance and abrasion control,
  • optional coupling agents for adhesion,
  • optimization of filler size distribution and morphology to control wear and maintain cleaning efficacy.

US 5,153,657 aligns with that playbook but attempts to pin down:

  • a mid-hardness filler band (4 to 7 Mohs),
  • filler geometry constraints (aspect ratio <10:1; cylindrical geometry in claim 7),
  • specific mean particle size (claim 5),
  • and coupling agents.

If prior art already teaches polyurethane-based wiper/scraper blades with inorganic wear fillers plus coupling agents, then novelty most likely reduces to the particular combination of:

  • hardness window,
  • specific filler size/shape ranges,
  • and the frictional cleaning “blade” application context.

Key claim sensitivity table (elements most likely to matter in enforcement)

Claim element Literal requirement Primary risk if prior art exists
Frictional cleaning blade function Blade removes particles via frictional engagement Prior art scraper/wiper patents can map to this easily
Thermoset elastomer matrix Thermoset elastomeric matrix body Prior polyurethane blades may be thermoset or crosslinked
Inorganic particulate filler Inorganic particulate dispersed in matrix “Wear filler in elastomers” is widely disclosed
Hardness 4 to 7 Mohs Filler hardness must fall in this band Prior art with overlapping silica/glass fillers can erode novelty
Aspect ratio <10:1 (claim 2) Shape constraint Prior art fibers/flakes can show overlap or obvious choice
Particle size ~2.5 μm (claim 5) Mean size near 2.5 μm Prior art distributions can be broad and not centered on 2.5 μm
Cylindrical morphology (claim 7) 1-3 μm diameter; 3-10 μm length Prior whisker/fiber patents may anticipate or render obvious
Coupling agent list (claims 8-9) Silanes/titanates/zirconates/aluminates Coupling agents are standard in composites

“Critical” reading of claim architecture: strengths and vulnerabilities

Strengths

  1. Hardness-limited filler window: The 4 to 7 Mohs range is a concrete numerical limitation that can distinguish from generic “abrasive filler” disclosures.
  2. Matrix constraint plus filler dispersion: Thermoset elastomer with substantially homogeneous dispersion provides an additional structural condition.
  3. Morphology and size constraints: Claim 5 and claim 7 provide quantitative guardrails that can be used for claim charts and prosecution history.

Vulnerabilities

  1. Breadth of inorganic filler identity: Enumerating many minerals and ceramics suggests the invention depends more on physical properties than on specific chemistry, which can reduce non-obviousness if prior art teaches similar hardness and wear fillers broadly.
  2. Standard composite components: Coupling agents and inorganic wear fillers are common in polymer systems. Claims 8 and 9 risk being viewed as an obvious adhesion improvement rather than a novel wear mechanism.
  3. Application context is likely crowded: “Cleaning blade in frictional engagement” is a common functional framing in scraper and wiper device patents; it may not provide strong novelty by itself.

Competitive patent strategy implications

What does this imply for freedom-to-operate work?

A clearance strategy should focus on comparing:

  • thermoset vs thermoplastic blade bodies,
  • filler hardness evidence (or proxy composition),
  • particle size distribution and whether it centers around ~2.5 μm,
  • filler morphology (aspect ratio and cylindrical geometry),
  • and the use and type of coupling agent.

For infringement, it is often the case that labs do not measure Mohs hardness or cylindrical dimensions directly. Instead, parties infer from composition and particle characterization. The claim is susceptible to evidentiary disputes centered on particle characterization.

Key Takeaways

  • US 5,153,657 claims a thermoset elastomer blade for frictional cleaning with inorganic particulate wear filler constrained by hardness (4 to 7 Mohs) (claim 1).
  • Enforceability hinges on whether prior art already discloses mid-hardness inorganic wear fillers in thermoset elastomer blade bodies for similar cleaning use.
  • Dependent claims add quantitative constraints that can matter in both validity and infringement: aspect ratio (<10:1), mean particle size (~2.5 μm), and cylindrical filler geometry (1-3 μm diameter; 3-10 μm length).
  • Coupling agents (silanes/titanates/zirconates/aluminates) are likely the weakest incremental novelty layer because they are standard polymer composite practice, unless the prior art combination is absent.
  • Landscape risk is concentrated around scraper/wiper elastomer compositions and filled thermoset polyurethane or similar elastomers with inorganic wear fillers and adhesion promoters.

FAQs

1. What is the single most important claim element for scope?
The combination of a frictional cleaning blade with a thermoset elastomeric matrix containing an inorganic particulate filler with hardness 4 to 7 Mohs (claim 1).

2. Which dependent claims add the tightest numerical limits?
Claim 5 (~2.5 μm mean particle size), claim 2 (aspect ratio <10:1), and claim 7 (cylindrical: 1 to 3 μm diameter and 3 to 10 μm length).

3. How do coupling-agent claims affect infringement?
Claims 8 and 9 narrow to filler particles treated with coupling agents including silanes/titanates/zirconates/aluminates. If a product uses untreated filler or different surface chemistry, it can avoid those dependent claims.

4. Does the long mineral list broaden or narrow the patent?
It broadens the potential design space covered under the dependent claims that require selection from that list, but it also signals that the core invention is property-driven (hardness/wear/morphology), which can weaken non-obviousness if prior art teaches similar property targets with different minerals.

5. What design change is most likely to avoid claim 1?
Switch either the matrix type away from thermoset elastomers, or choose an inorganic filler whose hardness is outside 4 to 7 Mohs.


References

[1] United States Patent 5,153,657. “Cleaning blade.” (Claims as provided in the prompt).

More… ↓

⤷  Start Trial

Details for Patent 5,153,657

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Pharmalucence Inc MICROLITE radiolabeled albumin technetium tc-99m albumin colloid kit 018263 March 25, 1983 5,153,657 2011-04-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.